ALNYLAM PHARMACEUTICALS INCALNYLAM PHARMACEUTICALS INCALNYLAM PHARMACEUTICALS INC

ALNYLAM PHARMACEUTICALS INC

No trades
See on Supercharts
Market capitalization
‪313.49 B‬MXN
−60.04MXN
‪−7.48 B‬MXN
‪31.05 B‬MXN
‪125.76 M‬
Beta (1Y)
1.35

About ALNYLAM PHARMACEUTICALS INC

CEO
Yvonne L. Greenstreet
Headquarters
Cambridge
Employees (FY)
‪2.1 K‬
Founded
2002
ISIN
US02043Q1076
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R. Schimmel, and Phillip Allen Sharp on June 14, 2002 and is headquartered in Cambridge, MA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where ALNY is featured.

Frequently Asked Questions

The current price of ALNY is 2453.00 MXN — it has decreased by 0.20% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange ALNYLAM PHARMACEUTICALS INC stocks are traded under the ticker ALNY.
ALNYLAM PHARMACEUTICALS INC is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
ALNY stock is 0.20% volatile and has beta coefficient of 1.35. Check out the list of the most volatile stocks — is ALNYLAM PHARMACEUTICALS INC there?
One year price forecast for ALNYLAM PHARMACEUTICALS INC has a max estimate of 6746.02 MXN and a min estimate of 2322.68 MXN.
ALNY earnings for the last quarter are 20.05 MXN per share, whereas the estimation was −25.20 MXN resulting in a 179.55% surprise. The estimated earnings for the next quarter are −20.15 MXN per share. See more details about ALNYLAM PHARMACEUTICALS INC earnings.
ALNYLAM PHARMACEUTICALS INC revenue for the last quarter amounts to ‪13.08 B‬ MXN despite the estimated figure of ‪6.92 B‬ MXN. In the next quarter revenue is expected to reach ‪7.42 B‬ MXN.
Yes, you can track ALNYLAM PHARMACEUTICALS INC financials in yearly and quarterly reports right on TradingView.
ALNY net income for the last quarter is ‪−2.34 B‬ MXN, while the quarter before that showed ‪2.58 B‬ MXN of net income which accounts for −190.93% change. Track more ALNYLAM PHARMACEUTICALS INC financial stats to get the full picture.
Today ALNYLAM PHARMACEUTICALS INC has the market capitalization of ‪313.49 B‬, it has decreased by 1.44% over the last week.
No, ALNY doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ALNY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ALNYLAM PHARMACEUTICALS INC stock right from TradingView charts — choose your broker and connect to your account.
ALNY reached its all-time high on Dec 8, 2022 with the price of 4682.29 MXN, and its all-time low was 1355.78 MXN and was reached on Jun 14, 2019.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has ‪2.10 K‬ employees. See our rating of the largest employees — is ALNYLAM PHARMACEUTICALS INC on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ALNYLAM PHARMACEUTICALS INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ALNYLAM PHARMACEUTICALS INC stock shows the strong sell signal. See more of ALNYLAM PHARMACEUTICALS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on ALNYLAM PHARMACEUTICALS INC future price: according to them, ALNY price has a max estimate of 6746.02 MXN and a min estimate of 2322.68 MXN. Read a more detailed ALNYLAM PHARMACEUTICALS INC forecast: see what analysts think of ALNYLAM PHARMACEUTICALS INC and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ALNYLAM PHARMACEUTICALS INC EBITDA is ‪−3.87 B‬ MXN, and current EBITDA margin is −12.48%. See more stats in ALNYLAM PHARMACEUTICALS INC financial statements.